Pregnant and breastfeeding women have been rendered therapeutic orphans as they have
been historically excluded from clinical trials. Labelling for most approved drugs does not …

There is an acute need for research to acquire high-quality information on the use of
medicines in pregnancy, both in terms of appropriateness and safety. For this purpose, the …

Safe medication use by women during pregnancy and lactation is an area of concern for
women and their health care providers. In December 2014, the US Food and Drug …

Scientists and regulators in Europe and the United States continue to seek methods and
strategies to improve knowledge on rational use of medicines for pregnant and …

Background: Prescribing drugs to pregnant women requires the balancing of benefits and
risks. Only a small proportion of drugs are known to be harmful to the fetus, but for the vast …

Die meisten akuten und chronischen Erkrankungen sprechen weder gegen das Austragen
einer Schwangerschaft, noch rechtfertigt eine Schwangerschaft das Vorenthalten einer …

Over 200 million pregnancies occur worldwide annually [1], yet pregnant women have
historically been excluded from clinical studies. However, women who are pregnant are not …

Although most drugs are used to treat chronic or pregnancy-induced conditions during
pregnancy and lactation, very few are studied in pregnant or breastfeeding women. The …

Objective To compare the prescription of drugs in women over a period from 2 years before
until 3 months after pregnancy, regarding the type of drugs used and the fetal risk. Design A …

Im vorliegenden Beitrag werden die Arzneimittelverordnungen des Jahres 2016 nach Alter
und Geschlecht der Patienten analysiert. Die Größen der Altersgruppen wurden dabei mit …